Savan Devani

Savan previously spent his entire professional and academic life in life sciences, including over 12 years working with hundreds of public and private corporations as a Healthcare Investment Banker at Citigroup, Deutsche Bank. From Analyst through Managing Director, Savan executed 40 M&A, IPO, and financing deals, totaling over $35 billion in value across the spectrum of drug, diagnostic, and device technologies. These companies included Amgen, Anacor, Boston Scientific, Eli Lilly, Intermune, Map Pharma, Masimo, Medtronic, Omeros, Pacific Biosciences, and many others. While a Vice President at Deutsche Bank, he was selected to lead the firm's build-out of its healthcare business into Asia, leading to two of China's largest IPO's.

Savan graduated with a M.S.E. in Bioengineering from the University of Pennsylvania and a B.S.E. in Bioengineering focused in Computer Science from the University of California at Berkeley.